SOPH
SOPHiA GENETICS SA
7.60$
-4.3%
vs. previous close
Closing price · As of: Oct 30, 2026
Ownership
Ownership Structure
Who owns SOPHiA GENETICS SA (SOPH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.9% of the shares are freely tradable; institutional investors hold 48.0%.
Institutional ownership
?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
48.0%
Insiders
?Share of the stock held by the executives, founders and major shareholders of the company itself.
7.0%
Float
?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
76.9%
Short % of float
?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
1.4%
Shares Outstanding
?Total number of shares issued. Price times share count gives market cap.
85Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Generation Investment Management LLP | 7.98 | 6,789,560 | +0.0 | 06/30/2026 |
| AIGH Capital Management, LLC | 4.65 | 3,954,194 | +0.0 | 06/30/2026 |
| Akre Capital Management, LLC | 4.37 | 3,719,140 | +0.0 | 06/30/2026 |
| Royce & Associates, LP | 3.97 | 3,381,736 | +86.2 | 06/30/2026 |
| Principal Financial Group Inc | 2.78 | 2,364,256 | +67.8 | 06/30/2026 |
| Ameriprise Financial Inc | 2.60 | 2,216,752 | +0.0 | 06/30/2026 |
| Banque Pictet & Cie SA | 2.59 | 2,208,280 | +0.0 | 06/30/2026 |
| Awm Investment Company Inc | 2.00 | 1,700,000 | +0.0 | 06/30/2026 |
| Soleus Capital Management, L.P. | 1.84 | 1,565,000 | -15.4 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Columbia Small Cap Growth Inst | 2.52 | 2,145,003 | +72.4 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Camblong Jurgi | Executive Chairman | 3,387,150 | 25,742,340 $ | Oct 12, 2026 | direct |
| Muken Ross | Chief Executive Officer | 660,391 | 5,018,972 $ | Oct 5, 2026 | direct |
| Xu Zhenyu | Chief Scientific Officer | 541,493 | 4,115,347 $ | Oct 13, 2026 | direct |
| Van Well Daan | Chief Legal Officer | 332,716 | 2,528,642 $ | Oct 5, 2026 | direct |
| Cardoza George | Chief Financial Officer | 306,726 | 2,331,118 $ | Oct 5, 2026 | direct |
| Valente Manuela | Chief People Officer | 206,210 | 1,567,196 $ | Oct 5, 2026 | direct |
| Menu Philippe | Chief Medical Officer | 195,993 | 1,489,547 $ | Oct 12, 2026 | direct |
| Verma Abhimanyu | Chief Technology Officer | 166,887 | 1,268,341 $ | Oct 5, 2026 | direct |
| Puylaert Kevin | Chief Sales Officer | 147,732 | 1,122,763 $ | Oct 5, 2026 | direct |
| Hibbs Kathy L | Director | 96,992 | 737,139 $ | Sep 8, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,000 | 7.18 | 28,727 |
| Oct 12, 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | 7.26 | 36,303 |
| Oct 12, 2026 | Camblong Jurgi | Executive Chairman | Sell | 8,500 | 7.26 | 61,671 |
| Oct 5, 2026 | Van Well Daan | Chief Legal Officer | Sell | 6,168 | 8.12 | 50,100 |
| Oct 5, 2026 | Valente Manuela | Chief People Officer | Sell | 4,240 | 8.13 | 34,487 |
| Oct 5, 2026 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,284 | 8.12 | 42,929 |
| Oct 5, 2026 | Puylaert Kevin | Chief Sales Officer | Sell | 31 | 7.92 | 246 |
| Oct 5, 2026 | Puylaert Kevin | Chief Sales Officer | Sell | 185 | 8.06 | 1,491 |
| Oct 5, 2026 | Cardoza George | Chief Financial Officer | Sell | 1,592 | 8.10 | 12,897 |
| Oct 5, 2026 | Menu Philippe | Chief Medical Officer | Sell | 7,394 | 8.13 | 60,100 |
| Oct 5, 2026 | Camblong Jurgi | Executive Chairman | Sell | 40,172 | 8.13 | 326,526 |
| Oct 5, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 7,394 | 8.12 | 60,075 |
| Oct 5, 2026 | Muken Ross | Chief Executive Officer | Sell | 9,838 | 8.13 | 79,971 |
| Sep 21, 2026 | Cardoza George | Chief Financial Officer | Sell | 774 | 8.33 | 6,447 |
| Sep 21, 2026 | Muken Ross | Chief Executive Officer | Sell | 422 | 8.33 | 3,515 |
| Sep 14, 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | 7.88 | 39,417 |
| Sep 14, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,000 | 7.88 | 31,538 |
| Sep 11, 2026 | Van Well Daan | Chief Legal Officer | Sell | 6,168 | 7.63 | 47,089 |
| Sep 10, 2026 | Camblong Jurgi | Executive Chairman | Sell | 8,500 | 7.66 | 65,120 |
| Sep 8, 2026 | Hibbs Kathy L | Director | Sell | 6,250 | 8.13 | 50,818 |
| Aug 27, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 10,000 | 8.91 | 89,096 |
| Aug 25, 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | 8.68 | 43,397 |
| Aug 25, 2026 | Hibbs Kathy L | Director | Sell | 6,250 | 8.68 | 54,233 |
| Aug 24, 2026 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,000 | 8.80 | 44,000 |
| Aug 21, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 5,408 | 8.40 | 45,447 |
| Aug 20, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,592 | 8.41 | 38,609 |
| Aug 19, 2026 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,000 | 8.20 | 41,000 |
| Aug 19, 2026 | Valente Manuela | Chief People Officer | Sell | 10,000 | 7.94 | 79,439 |
| Aug 19, 2026 | Valente Manuela | Chief People Officer | Other | 10,000 | 3.20 | 32,000 |
| Aug 19, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 10,000 | 7.94 | 79,427 |
| Aug 13, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,000 | 7.52 | 30,076 |
| Aug 12, 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | 7.52 | 37,580 |
| Aug 10, 2026 | Camblong Jurgi | Executive Chairman | Sell | 8,500 | 7.61 | 64,669 |
| Aug 7, 2026 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,000 | 7.60 | 38,000 |
| Aug 7, 2026 | Camblong Jurgi | Executive Chairman | Sell | 20,000 | 7.23 | 144,540 |
| Aug 7, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 10,000 | 7.48 | 74,759 |
| Aug 7, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 7,000 | 7.02 | 49,152 |
| Aug 7, 2026 | Xu Zhenyu | Chief Scientific Officer | Other | 7,000 | 3.28 | 22,960 |
| Aug 5, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 3,000 | 7.00 | 21,013 |
| Aug 5, 2026 | Xu Zhenyu | Chief Scientific Officer | Other | 3,000 | 3.28 | 9,840 |
| Aug 4, 2026 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,000 | 6.95 | 34,772 |
| Aug 4, 2026 | Camblong Jurgi | Executive Chairman | Sell | 20,000 | 6.92 | 138,412 |
| Aug 4, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 10,000 | 6.92 | 69,168 |
| Jul 27, 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | 5.66 | 28,306 |
| Apr 20, 2026 | Jurgi Camblong | CEO | Sell | 4,486 | 5.21 | 23,372 |
| Apr 20, 2026 | Kevin Puylaert | Insider | Sell | 33 | 5.08 | 168 |
| Apr 20, 2026 | Manuela Valente | Insider | Sell | 380 | 5.20 | 1,976 |
| Apr 20, 2026 | Philippe Menu | Insider | Sell | 608 | 5.20 | 3,162 |
| Apr 20, 2026 | Ross Muken | President | Sell | 760 | 5.20 | 3,952 |
| Apr 20, 2026 | Well Daan Van | Insider | Sell | 684 | 5.20 | 3,557 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.